Form D · Biotechnology

VADovations, Inc.

Oklahoma City, OK · CIK 0001658620

Offering snapshot reported Dec 3, 2019 · SEC filing

Reported sold
$5M
Offering amount: $5M
Investors reported
1
Form D · investor count
Minimum accepted
$5M
Reported outside-investor minimum
First sale
Nov 26, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 3, 2019Initial$5,000,000No comparison1SEC filing
Nov 18, 2015Initial$2,000,000No comparison1SEC filing

Offering details

Securities
Debt, Other
Exemptions
06b, 4a5
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-354608
Convertible promissory note

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
VADovations, Inc.None

Source: Form D, filed Dec 3, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Lawrence C. Bruce Director
Kurt Dasse Director, Executive
Peter Dulaney Director
John B. Frick Director
Kathryn Ingerly Executive
John W. Long Director, Executive
James W. Long Director, Executive
Karl E. Nelson Executive
Karl E. Nelson, R.N., M.B.A. Executive
Timothy Pearson Director
Allison Petersen Executive
Stephen M. Prescott Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1333 Cornell Parkway
Oklahoma City, OK, 73108-1809